Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin
- 24 April 2012
- journal article
- Published by Springer Nature in Endocrine
- Vol. 42 (3) , 754-755
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatmentsEndocrine, 2011
- Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han malesEndocrine, 2011
- Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic miceCardiovascular Diabetology, 2011
- Role of silymarin to treat fibrosis development in non‐alcoholic fatty liver diseaseHepatology Research, 2011
- Role of adipocytokines in predicting the development of diabetes and its late complicationsEndocrine, 2009